NO20056006L - Aminsalter av (-)-{[2-(4-hydroksyfenyl)etyl]tio}-3-[4-(2-{4-[(metylsulfonyl)oksy]etyl)fenyl]propansyre og deres anvendelse som medikament - Google Patents

Aminsalter av (-)-{[2-(4-hydroksyfenyl)etyl]tio}-3-[4-(2-{4-[(metylsulfonyl)oksy]etyl)fenyl]propansyre og deres anvendelse som medikament

Info

Publication number
NO20056006L
NO20056006L NO20056006A NO20056006A NO20056006L NO 20056006 L NO20056006 L NO 20056006L NO 20056006 A NO20056006 A NO 20056006A NO 20056006 A NO20056006 A NO 20056006A NO 20056006 L NO20056006 L NO 20056006L
Authority
NO
Norway
Prior art keywords
ethyl
salt
methylsulfonyl
thio
hydroxyphenyl
Prior art date
Application number
NO20056006A
Other languages
English (en)
Norwegian (no)
Inventor
Bengt Ohlsson
Nigel Phillip Taylor
Mikael Ulf Johan Dahlstrom
Matti Ahlqvist
Richard Anthony Storey
Rebecca Woods
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20056006L publication Critical patent/NO20056006L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20056006A 2003-06-18 2005-12-16 Aminsalter av (-)-{[2-(4-hydroksyfenyl)etyl]tio}-3-[4-(2-{4-[(metylsulfonyl)oksy]etyl)fenyl]propansyre og deres anvendelse som medikament NO20056006L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314130.6A GB0314130D0 (en) 2003-06-18 2003-06-18 Therapeutic agents
PCT/GB2004/002576 WO2004113283A1 (en) 2003-06-18 2004-06-16 Amine salts of (-)-2-{`2-(4-hydroxyphenyl) ethyl!-thio}-3-`4-(2-{4-`(methylsulfonyl)oxy! phenoxy}ethyl)phenyl! propanoic acid and there use in medicine

Publications (1)

Publication Number Publication Date
NO20056006L true NO20056006L (no) 2006-02-24

Family

ID=27636789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056006A NO20056006L (no) 2003-06-18 2005-12-16 Aminsalter av (-)-{[2-(4-hydroksyfenyl)etyl]tio}-3-[4-(2-{4-[(metylsulfonyl)oksy]etyl)fenyl]propansyre og deres anvendelse som medikament

Country Status (20)

Country Link
US (1) US20070099928A1 (ru)
EP (1) EP1638930A1 (ru)
JP (1) JP3927594B2 (ru)
KR (1) KR20060023165A (ru)
CN (1) CN1835919A (ru)
AR (1) AR044826A1 (ru)
AU (1) AU2004249483A1 (ru)
BR (1) BRPI0411580A (ru)
CA (1) CA2529544A1 (ru)
CO (1) CO5630026A2 (ru)
GB (1) GB0314130D0 (ru)
IL (1) IL172633A0 (ru)
IS (1) IS8224A (ru)
MX (1) MXPA05013718A (ru)
NO (1) NO20056006L (ru)
RU (1) RU2005141061A (ru)
TW (1) TW200503671A (ru)
UY (1) UY28372A1 (ru)
WO (1) WO2004113283A1 (ru)
ZA (1) ZA200510263B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104333D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
WO2004000790A1 (en) 2002-06-20 2003-12-31 Astrazeneca Ab Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
GB0314131D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314075D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0427524D0 (en) 2004-12-16 2005-01-19 Astrazeneca Ab Chemical process
GB0427701D0 (en) * 2004-12-17 2005-01-19 Astrazeneca Ab Therapeutic agents
MX2009007670A (es) * 2007-01-18 2011-11-18 Evolva Sa 1,3-dioxanos sustituidos utiles como moduladores de paar.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE0104333D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
BRPI0411580A (pt) 2006-08-08
IS8224A (is) 2006-01-10
CO5630026A2 (es) 2006-04-28
TW200503671A (en) 2005-02-01
EP1638930A1 (en) 2006-03-29
AR044826A1 (es) 2005-10-05
GB0314130D0 (en) 2003-07-23
UY28372A1 (es) 2005-01-31
CA2529544A1 (en) 2004-12-29
AU2004249483A1 (en) 2004-12-29
CN1835919A (zh) 2006-09-20
WO2004113283A1 (en) 2004-12-29
IL172633A0 (en) 2006-04-10
KR20060023165A (ko) 2006-03-13
RU2005141061A (ru) 2006-08-27
MXPA05013718A (es) 2006-06-27
JP3927594B2 (ja) 2007-06-13
JP2006527749A (ja) 2006-12-07
ZA200510263B (en) 2007-02-28
US20070099928A1 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
NO20056006L (no) Aminsalter av (-)-{[2-(4-hydroksyfenyl)etyl]tio}-3-[4-(2-{4-[(metylsulfonyl)oksy]etyl)fenyl]propansyre og deres anvendelse som medikament
BR112012027062A2 (pt) composto, processo para a preparação de um composto, método para prevenção e/ou tratamento de doenças e condições, e, composição farmacêutica
EP3298001B1 (en) Dgat2 inhibitors
NO20081482L (no) Delta- og epsilon-krystallformer for imatinibmesylat
JO3006B1 (ar) املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك
BR112014009717A2 (pt) "derivados de 2-(fenil ou pirid-3-il)aminopirimidina, seus usos, e composição farmacêutica"
US9073901B2 (en) DGAT2 inhibitors
BR112013019667A2 (pt) derivados de heteroaril-piperidina e -piperazina como fungicidas
CO6251286A2 (es) Sales amino del acido [4, 6-bis(dimetilamino)-2-(4-(4-trifluorometil)benzamido)bencil)pirimidin-5-il]acetico, composiciones farmaceuticas de las mismas y sus usos para el tratamiento de enfermedades mediadas por crth-2
BRPI0407814A (pt) derivados de ácido 3-metil-2-(3-(2-fenil-oxazol-4-ilmetoxi)-ciclohexonaca rbonil-amino)-butìrico e compostos afins como moduladores ppar para o tratamento do diabetes tipo 2 e aterosclerose
BR112014001587A2 (pt) derivados de ácido 3-(tiazol-4-carbonil)- ou 3-(tiazol-2-carbonil) amino-propiônico substituídos e seu uso como produtos farmacêuticos
JP2013526520A5 (ru)
BRPI0921593B8 (pt) processo para preparar compostos de 4-[2-(2-fluorofenoximetil)fenil]piperidina e compostos relacionados
PE20091213A1 (es) Formas solidas de acido (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-metoxibifenil-4-il)etoxi)pirimidin-4-il)fenil)propanoico
NO20055927L (no) Kalium- eller natriumsalt av (-)-2-{[2-(4-Hydroksyfenyl)Etyl]-Tio}-3-[4-(2-{4-[ (Metylsulfonyl)Oksy]Fenoksy}Etyl)Fenyl]Propansyre og deres anvendelse i medisin
NO20055883L (no) Fremgangsmate for fremstilling av racemisk 2-{[2-(4-hydroksfenyl)etyl]tio}-3-[4-(2-{4-[(metylsulfonyl)oksy]fenoksy}etyl)fenyl]-propansyre
BRPI0601773A (pt) compostos de fenilpiridilpiperazina, um processo para a preparação dos mesmos e composições farmacêuticas contendo os mesmos
TW200640843A (en) Therapeutic agents
BR112014010462A2 (pt) processo para a preparação de acilguanidinas e acetioureias
WO2007093747A3 (fr) Utilisation du tesaglitazar pour la preparation d'une composition pharmaceutique destinee au traitement des affections dermatologiques
BR112013027982A2 (pt) derivados de isoindolinona
ES2803654T3 (es) Inhibidores de DGAT2
TH87765B (th) สารรักษาโรค
TH81759A (th) สารสำหรับใช้บำบัดโรค
BRPI0900030A2 (pt) compostos de 1h-indol-1-il-uréia, um processo para sua preparação e composições farmacêuticas contendo-os

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application